Table 2.
Samples for MRW and POPUP per PROM
| Patients with MG from MRW | General population | |
|---|---|---|
| PROMIS-Dyspnea Characteristics | N = 325 | US COVID population [19] N = 126, pre-COVID scores |
| FACIT-Fatigue | N = 324 | German general population [22], N = 2576 |
| PROMIS-Sleep Disturbance | N = 251 | US population |
| EQ-5D-5L and six bolt-on questions | N = 1299 | POPUP, N = 9000 |
| MG-ADL | N = 1236 | POPUP, N = 9000 |
| MG-QoL-15r | N = 1177 | POPUP, N = 9000 |
| HUI-3 | N = 540 | POPUP, N = 9000 |
| HADS | N = 1159 | POPUP, N = 9000 |
PROMIS Patient-Reported Outcomes Measurement Information System, FACIT Functional Assessment of Chronic Illness Therapy, EQ-5D-5L EuroQol 5-Dimension 5-Level questionnaire, MG-ADL Myasthenia Gravis Activities of Daily Living, MG-QoL-15r MG Quality of Life questionnaire, HUI-3 Health Utilities Index Mark, HADS Hospital Anxiety and Depression Scale, MRW MyRealWorld-MG Digital study, POPUP General Population study, N sample size